(Q40420574)

20 September 2017

title

Comparison of IgG and F(ab')2 fragments of bispecific anti-RCCxanti-DTIn-1 antibody for pretargeting purposes (English)

1 reference

20 September 2017

2

Otto C Boerman

1 reference

20 September 2017

Frank G van Schaijk

1

1 reference

20 September 2017

Annemieke C Soede

3

1 reference

20 September 2017

William J McBride

4

1 reference

20 September 2017

David M Goldenberg

5

1 reference

20 September 2017

Frans H M Corstens

6

1 reference

20 September 2017

Egbert Oosterwijk

7

1 reference

20 September 2017

publication date

18 May 2005

1 reference

European Journal of Nuclear Medicine and Molecular Imaging

20 September 2017

published in

1 reference

20 September 2017

volume

32

1 reference

20 September 2017

issue

9

1 reference

20 September 2017

page(s)

1089-1095

1 reference

https://scigraph.springernature.com/pub.10.1007/s00259-005-1796-x

20 September 2017

exact match

0 references

cites work

Optimizing bispecific antibody pretargeting for use in radioimmunotherapy

1 reference

12 December 2020

Pretargeted radioimmunotherapy of cancer: progress step by step

1 reference

12 December 2020

Targeted therapy of cancer with radiolabeled antibodies

1 reference

12 December 2020

Development and characterization of anti-renal cell carcinoma x antichelate bispecific monoclonal antibodies for two-phase targeting of renal cell carcinoma

1 reference

12 December 2020

High-dose myeloablative radioimmunotherapy of mantle cell non-Hodgkin lymphoma with the iodine-131-labeled chimeric anti-CD20 antibody C2B8 and autologous stem cell support. Results of a pilot study

1 reference

12 December 2020

Targeting of indium 111-labeled bivalent hapten to human melanoma mediated by bispecific monoclonal antibody conjugates: imaging of tumors hosted in nude mice.

1 reference

12 December 2020

Pretargeted radioimmunotherapy of human colorectal xenografts with bispecific antibody and 131I-labeled bivalent hapten

1 reference

12 December 2020

Monoclonal antibody hapten radiopharmaceutical delivery

1 reference

12 December 2020

Pretargeting with bispecific anti-renal cell carcinoma x anti-DTPA(In) antibody in 3 RCC models.

1 reference

12 December 2020

Pharmacokinetics and Tumor Targeting of 131I-Labeled F(ab9)2 Fragments of the Chimeric Monoclonal Antibody G250: Preclinical and Clinical Pilot Studies

1 reference

12 December 2020

Experimental studies on the role of antibody fragments in cancer radio-immunotherapy: Influence of radiation dose and dose rate on toxicity and anti-tumor efficacy

1 reference

12 December 2020

Experimental pretargeting studies of cancer with a humanized anti-CEA x murine anti-[In-DTPA] bispecific antibody construct and a (99m)Tc-/(188)Re-labeled peptide.

1 reference

12 December 2020

Biodistribution and radiation dose estimates for yttrium- and iodine-labeled monoclonal antibody IgG and fragments in nude mice bearing human colonic tumor xenografts

1 reference

12 December 2020

Pretargeting of renal cell carcinoma: improved tumor targeting with a bivalent chelate

1 reference

12 December 2020

Radioimmunotherapy: recent results and future directions

1 reference

12 December 2020

Molecular advances in pretargeting radioimunotherapy with bispecific antibodies.

1 reference

12 December 2020

Monoclonal antibody G 250 recognizes a determinant present in renal-cell carcinoma and absent from normal kidney

1 reference

12 December 2020

Two-step targeting of xenografted colon carcinoma using a bispecific antibody and 188Re-labeled bivalent hapten: biodistribution and dosimetry studies

1 reference

12 December 2020

Protein and cell membrane iodinations with a sparingly soluble chloroamide, 1,3,4,6-tetrachloro-3a,6a-diphenylglycoluril

1 reference

12 December 2020

Reducing the renal uptake of radiolabeled antibody fragments and peptides for diagnosis and therapy: present status, future prospects and limitations

1 reference

12 December 2020

MN/CA IX/G250 as a potential target for immunotherapy of renal cell carcinomas

1 reference

12 December 2020

Development of new multivalent-bispecific agents for pretargeting tumor localization and therapy

1 reference

12 December 2020

Metabolism of indium-111-labeled murine monoclonal antibody in tumor and normal tissue of the athymic mouse

1 reference

12 December 2020

Establishment and characterization of human renal cancer and normal kidney cell lines

1 reference

12 December 2020

Cure of metastatic human colonic cancer in mice with radiolabeled monoclonal antibody fragments

1 reference

12 December 2020

10.1007/S00259-005-1796-X

Identifiers

DOI

1 reference

20 September 2017

1 reference